MarginsXMarginsX
Home › Markets › Health Care › ENLV

Enlivex Ltd. (ENLV)

ENLV trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.12
-5.88% on the day
Market cap
$1.7M
Nano cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerENLV on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryIsrael
IPO year2014
SEC CIK0001596812
SEC industry codeFinance Services
Incorporated inIsrael

Financials

Foreign filer: no machine-readable annual figure in SEC data.

Warning signs

Cash runway
2.2 months
$1.9M cash at December 31, 2025
Share count, 1 year
+903.7%
2024-12-31 to 2025-12-31 · +1188.6% over 3 years
Going-concern doubt
No
20-F filed March 25, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-03-25
Cash and burn$1.9M cash; operating cash flow -$2.6M a quarter.Report 2025-12-31
Shares outstanding989,090 (2025-12-31); 23,650,989 a year earlier; 18,421,852 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 years2; latest 1-for-16 on 2026-10-27Source 2026-10-27
Shelf and offerings, 12 months3 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2025-11-24
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorYarel + Partners, Tel Aviv-Yafo, IsraelPCAOB Form AP 2026-04-02
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30
Market cap checkThe listing's market cap implies 1,531,995 shares at the 2026-11-13 price; the latest SEC cover count is 989,090 as of 2025-12-31, 989,090 after the 1-for-15 and 1-for-16 splits since. The SEC count is the older of the two, so the listing's cap is likely the current one; shares were issued since that cover page.Nasdaq screener and SEC cover page

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
Not filed$1.2B-$10.4M$1.9MNo debt tagsNeeds four quarters20-F 2026-03-25
FY 2024
2024-12-31
Not filed-$15.0M-$13.0M$3.3MNo debt tagsNeeds four quarters20-F 2026-03-25
FY 2023
2023-12-31
Not filed-$29.1M-$23.5M$813KNo debt tagsNeeds four quarters20-F 2026-03-25
FY 2022
2022-12-31
Not filed-$31.1M-$24.0M$49.9MNo debt tagsNeeds four quarters20-F 2025-04-30
FY 2021
2021-12-31
Not filed-$14.5M-$17.5M$11.2MNo debt tagsNeeds four quarters20-F 2024-04-30
FY 2020
2020-12-31
Not filed-$11.8M-$11.0M$5.7MNo debt tagsNeeds four quarters20-F 2023-04-10
FY 2019
2019-12-31
Not filed-$9.4M-$7.0M$3.9MNo debt tagsNeeds four quarters20-F 2022-04-29
FY 2018
2018-12-31
Not filed-$4.2M-$3.2M$9.7MNo debt tagsNeeds four quarters20-F 2021-04-30

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B32026-08-17
Latest annual report
ANNUAL REPORT
20-F2026-03-25
Latest quarterly / interim
REPORT OF FOREIGN PRIVATE ISSUER
6-K2026-11-16

Source: SEC EDGAR submissions feed, 420 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-6.3%
1 month+436.0%
3 months-29.6%
Year to date-88.7%
1 year-92.0%
From 52-week high-93.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
SXTP60 Degrees Pharmaceuticals Inc.$0.4938-4.65%$1.7M
HCWBHCW Biologics Inc.$0.8000+3.48%$1.8M
ARTLArtelo Biosciences Inc.$1.70-17.87%$1.6M
XRTXXORTX Therapeutics Inc. Common Shares$1.04-5.45%$1.9M
ONCOOnconetix Inc.$2.91-9.35%$1.9M
PPCBPropanc Biopharma Inc.$1.89-2.62%$2.0M
APVOAptevo Therapeutics Inc.$0.5486-7.66%$1.5M
CMNDClearmind Medicine Inc. Common Shares$4.18-7.67%$2.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier